• Xianghe Business Consulting (Beijing) participated in multiple private financing rounds for Valhalla Tech, a multimodal molecular “world model” developer, raising nearly USD 50 million in three months.
• Proceeds will fund team expansion, upgrades to its AlloDesign multimodal generative molecular model, and continued wet-lab validation to support a Scientific AGI platform.
• Valhalla Tech targets drug discovery as its initial commercialization focus, offering bespoke molecule development for targets and industrial model licensing to global pharma and biotech clients.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xianghe Business Consulting (Beijing) Co Ltd published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein.